Deep Track Capital, LP Immunovant, Inc. Transaction History

Deep Track Capital, LP

$3.17 Billion
Q3 2025

A detailed history of Deep Track Capital, LP transactions in Immunovant, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 9,728,845 shares of IMVT stock, worth $268 Million. This represents 8.45% of its overall portfolio holdings.

Number of Shares

9,728,845

Previous 9,500,000 2.41%

Holding current value

$268 Million

Previous $261 Million 2.41%

% of portfolio

8.45%

Previous 9.27%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	N/A	228,845 Added 2.41%	9,728,845 $268 Million
Q1 2025 May 15, 2025	BUY	N/A	3,500,000 Added 58.33%	9,500,000 $261 Million
Q4 2024 Feb 14, 2025	BUY	N/A	1,652,536 Added 38.01%	6,000,000 $165 Million
Q3 2024 Nov 14, 2024	BUY	$27.51 - $27.51 $40.3 Million - $40.3 Million	1,463,728 Added 50.76%	4,347,464 $120 Million
Q2 2024 Aug 14, 2024	BUY	$25.1 - $31.61 $60 Million - $75.6 Million	2,390,384 Added 484.52%	2,883,736 $76.1 Million
Q1 2024 May 15, 2024	SELL	$30.27 - $43.79 $15.3 Million - $22.2 Million	-506,648 Reduced 50.66%	493,352 $15.9 Million
Q4 2023 Feb 14, 2024	SELL	$31.31 - $44.19 $56.3 Million - $79.5 Million	-1,797,955 Reduced 64.26%	1,000,000 $42.1 Million
Q3 2023 Nov 14, 2023	SELL	$18.55 - $39.96 $48.7 Million - $105 Million	-2,623,375 Reduced 48.39%	2,797,955 $107 Million
Q2 2023 Aug 14, 2023	SELL	$14.2 - $23.75 $28.6 Million - $47.8 Million	-2,011,387 Reduced 27.06%	5,421,330 $103 Million
Q1 2023 May 15, 2023	SELL	$15.27 - $19.72 $34.8 Million - $44.9 Million	-2,277,283 Reduced 23.45%	7,432,717 $115 Million
Q4 2022 Feb 14, 2023	SELL	$6.59 - $17.75 $990,121 - $2.67 Million	-150,246 Reduced 1.52%	9,710,000 $172 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $1.59 Million - $2.58 Million	405,246 Added 4.29%	9,860,246 $55 Million
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.65 $7.54 Million - $12.6 Million	2,230,387 Added 30.87%	9,455,000 $36.9 Million
Q1 2022 May 16, 2022	BUY	$5.06 - $8.77 $12.4 Million - $21.5 Million	2,449,613 Added 51.3%	7,224,613 $39.8 Million
Q4 2021 Feb 14, 2022	BUY	$7.33 - $9.32 $35 Million - $44.5 Million	4,775,000 New	4,775,000 $40.7 Million

Others Institutions Holding IMVT

# of Institutions

214

Shares Held

81.6M

Call Options Held

597K

Put Options Held

704K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Account

Deep Track Capital, LP Immunovant, Inc. Transaction History